8 Einträge gefunden

1. Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: A study of the Chronic Malignancies Working Party of EBMT

   1. Hernández-Boluda, Juan Carlos
   2. Eikema, Diderik-Jan
   3. Koster, Linda
   4. Kröger, Nicolaus
   5. Robin, Marie
   6. de Witte, Moniek
   7. Finke, Jürgen

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

   1. Czerw, Tomasz
   2. Iacobelli, Simona
   3. Malpassuti, Vittoria
   4. Koster, Linda
   5. Kröger, Nicolaus
   6. Robin, Marie
   7. Maertens, Johan

   2022 - Forschungsinformationssystem des UKE
3. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

   1. Polverelli, Nicola
   2. Mauff, Katya
   3. Kröger, Nicolaus
   4. Robin, Marie
   5. Beelen, Dietrich
   6. Beauvais, David
   7. Chevallier, Patrice

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

   1. Nabergoj, Mitja
   2. Mauff, Katya
   3. Robin, Marie
   4. Kröger, Nicolaus
   5. Angelucci, Emanuele
   6. Poiré, Xavier
   7. Passweg, Jakob

   2021 - Forschungsinformationssystem des UKE
5. Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation

   1. Hernández-Boluda, Juan Carlos
   2. Pereira, Arturo
   3. Kröger, Nicolaus
   4. Beelen, Dietrich
   5. Robin, Marie
   6. Bornhäuser, Martin
   7. Angelucci, Emanuele

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

   1. Kröger, Nicolaus
   2. Sbianchi, Giulia
   3. Sirait, Tiarlan
   4. Wolschke, Christine
   5. Beelen, Dietrich
   6. Passweg, Jakob
   7. Robin, Marie

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

   1. Kröger, Nicolaus
   2. Iacobelli, Simona
   3. Franke, Georg-Nikolaus
   4. Platzbecker, Uwe
   5. Uddin, Ruzena
   6. Hübel, Kai
   7. Scheid, Christof

   2017 - Forschungsinformationssystem des UKE
8. Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?

   1. de Witte, Theo M
   2. Bowen, David
   3. Robin, Marie
   4. Malcovati, Luca
   5. Mufti, Ghulam
   6. Niederwieser, Dietger
   7. Yakoubagha, Ibrahim

   2014 - Forschungsinformationssystem des UKE